---
schema_version: "secwatch.filing_event.v1"
accession: "0001034842-26-000007"
form_type: "8-K"
ticker: "RIGL"
cik: "0001034842"
company_name: "RIGEL PHARMACEUTICALS INC"
filed_at: "2026-02-03T23:59:59+00:00"
generated_at: "2026-05-16T05:13:19.751324+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Rigel appoints Michael P. Miller to board, effective Feb 1, 2026

## Summary
- Michael P. Miller appointed to Rigel board effective Feb 1, 2026; term expires at 2027 annual meeting.
- Miller will serve on Compensation Committee; receives $50k annual retainer plus $10k for committee.
- Initial option grant of 12,000 shares under 2018 Plan; annual grants of 3,000 options + 2,500 RSUs thereafter.
- Board determined Miller is independent under applicable standards; no family relationships or transactions.

## SEC filing metadata
- accession: 0001034842-26-000007
- form_type: 8-K
- ticker: RIGL
- cik: 0001034842
- company_name: RIGEL PHARMACEUTICALS INC
- filed_at: 2026-02-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/0001034842-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1034842/000103484226000007/rigl-20260201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001034842-26-000007
- JSON: https://secwatch.observer/filing/0001034842-26-000007.json
- Plain text: https://secwatch.observer/filing/0001034842-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.